SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-15-004210
Filing Date
2015-07-02
Accepted
2015-07-02 14:14:20
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K nbio_10k.htm 10-K 404930
2 CERTIFICATION nbio_ex311.htm EX-31.1 9621
3 CERTIFICATION nbio_ex312.htm EX-31.2 9536
4 CERTIFICATION nbio_ex321.htm EX-32.1 3305
5 CERTIFICATION nbio_ex322.htm EX-32.2 3282
  Complete submission text file 0001477932-15-004210.txt   1982871

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nbio-20150331.xml EX-101.INS 233940
7 XBRL TAXONOMY EXTENSION SCHEMA nbio-20150331.xsd EX-101.SCH 30575
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20150331_cal.xml EX-101.CAL 36101
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20150331_def.xml EX-101.DEF 48255
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20150331_lab.xml EX-101.LAB 176412
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20150331_pre.xml EX-101.PRE 135925
Mailing Address 8400 MIRAMAR ROAD SUITE 247 SAN DIEGO CA 92126
Business Address 8400 MIRAMAR ROAD SUITE 247 SAN DIEGO CA 92126 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-55299 | Film No.: 15968764
SIC: 2834 Pharmaceutical Preparations